Fintech PR
#Greentech: MECAWARE secures €40m to become the leader in battery recycling and the production of strategic metals in France and Europe
LYON, France, Oct. 6, 2023 /PRNewswire/ — In order to speed up its industrial and commercial development, MECAWARE has secured €40 million from a pool of investors, the French government, under the auspices of the France 2030 plan, and its banking partners.
This funding will enable the industrialisation of the pilot scheme for the recycling of battery production scrap (Gigafactories Scrap – ScrapCO2MET project), which will be operational in 2025. This tool will produce 50 tonnes of recycled metal per year, in particular, lithium, nickel, cobalt and manganese. To prepare for this development, MECAWARE is finalising the installation of its new Technical Centre on the outskirts of Lyon (Vénissieux). This 1,600m2 site includes offices, an R&D laboratory and a factory building.
MECAWARE, the only metal extraction process of its kind in the world
MECAWARE is currently focusing on the recycling of end-of-life batteries and production scrap from battery-making factories. Its technology is based on ground-breaking innovation in dynamic combinatorial chemistry. It uses the synergy caused from the capture of CO2 and the recycling of critical metals. Subject to four patents, it was recognised in 2020 by the American Chemical Society and the Nature Chemistry journal.
Its application enables the extraction of metals in a closed loop, free from inputs that impact the environment, without producing any effluent and with no special energy requirements. Consequently, its economic and ecological value is particularly appealing: the MECAWARE eco²-efficiency adapts to feedstocks and to evolutions in battery technology.
Arnaud Villers d’Arbouet, Co-Founder and CEO of MECAWARE explains: “MECAWARE is thus deploying a ground-breaking and scalable industrial solution as part of a circular economy approach. It makes it possible to secure supplies of raw materials, enabling the strategic independence of our territories to bolster the energy transition, all in compliance with EU Regulations. Our technological solution addresses the current problems caused by traditional processes.”
€40m to meet MECAWARE’s industrial development challenges
This fundraising operation carried out with a pool of investors was organised by Crédit Mutuel Innovation and the SPI2 fund managed on behalf of the State of France by Bpifrance as part of the France 2030 initiative. It was supported by some of MECAWARE’s long-standing investment partners, who thus consolidated their positions: EIT InnoEnergy, UI Investissement, Kreaxi, BNP Paribas Développement, Crédit Agricole Création. It follows on from the obtainment, at the start of the year, of State subsidies under the France 2030 Plan (ADEME, RRR) awarded to the ScrapCO2MET project in partnership with the companies VERKOR and MTB. This funding should also be supplemented by bank support provided by BNP Paribas, CIC, CERA and Bpifrance.
This fundraising will also enable the development of the operational governance of commercial activities and the structuring of the teams involved (workforces will increase from 40 people at the end of 2023 to 80 in 2024).
For Stéphane Simoncini, Director and head of the Deeptech hub at Crédit Mutuel Innovation: “We are proud to support Arnaud and his team in this new phase of their development. MECAWARE’s mission is to support the decarbonisation of transport in a virtuous manner. They are taking the lead in the strategic segment of recycling electric batteries and their metals and building an impressive ecosystem around themselves in the process.”
Magali Joessel, Director of the SPI Fund, comments: “The development of electrical mobility goes hand in hand with key issues regarding the procurement of raw materials in terms of both sovereignty and the environment. We are convinced that Mecaware’s technology, which seeks to recycle and recover blackmass from end-of-life batteries or production scrap constitutes a valid response to these challenges. The metal extraction process they have created is an innovative solution that fits into the development of the French battery sector. Preparing the industrialisation of Mecaware and supporting its shift in scale chime perfectly with the raison d’être of the SPI Fund.“
Focus on the development of ground-breaking innovation to benefit the circular economy and energy transition.
The chemical process used by MECAWARE, the only one of its kind in the world, was created through French public research. It was developed by Professor Julien Leclaire at the Applied Supramolecular Chemistry Laboratory in Lyon (ICBMS: Université Claude Bernard Lyon 1, INSA Lyon, CPE Lyon and CNRS). After an initial technological development phase conducted by SATT Sud-Est, this technology received significant investment and support from PULSALYS to decrypt and optimise the lab chemistry and define various processes protected by 3 patents, 2 of which are jointly owned with Aix-Marseille Université, Centrale Marseille and the ENSC in Montpellier. The support provided by SATT PULSALYS enabled the creation of the start-up in 2020 after the arrival of Arnaud Villers d’Arbouet as its co-founder and CEO.
Logo – https://mma.prnewswire.com/media/2239866/MECAWARE_Logo.jpg
Contact:
Véronique Bourgeois
vb@monet-rp.com
View original content:https://www.prnewswire.co.uk/news-releases/greentech-mecaware-secures-40m-to-become-the-leader-in-battery-recycling-and-the-production-of-strategic-metals-in-france-and-europe-301948777.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
Al Hassan Ghazi Ibrahim Shaker Co. announces a strong start to FY24, reporting a 12.09% YoY increase in net profit to reach SAR 32.25 million in Q1-FY24
-
Latest News5 days ago
Newgen Recognized in the Gartner® Market Guide for Commercial Banking Cash Management and Trade Finance Solutions 2023 Report
-
Latest News5 days ago
Major Korean pension fund invests in carbon solutions with Stafford Capital Partners
-
Latest News5 days ago
Precisely Showcases Critical Role of Trusted Data in AI at the Gartner® Data & Analytics Summit in London
-
Latest News5 days ago
One United Properties posts a consolidated turnover of 84.3 million euros and a gross profit of 37 million euros in the first three months of 2024
-
Latest News5 days ago
XREX Singapore Receives MAS Major Payment Institution Licence
-
Latest News5 days ago
Vantage Markets Celebrates Mother’s Day with NEOM McLaren Extreme E Driver, Cristina Gutiérrez
-
Latest News4 days ago
KuCoin Research Report Reveals: $1 Billion in Financing and Rising Stablecoin Issuance Amid Market Fluctuations